Citadel Advisors’s QuidelOrtho QDEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $279K | Buy |
17,000
+2,200
| +15% | +$54K | ﹤0.01% | 10635 |
|
|
2025
Q4 | $423K | Sell |
14,800
-15,500
| -51% | -$420K | ﹤0.01% | 9423 |
|
|
2025
Q3 | $892K | Buy |
30,300
+8,900
| +42% | +$243K | ﹤0.01% | 7777 |
|
|
2025
Q2 | $617K | Buy |
21,400
+7,500
| +54% | +$222K | ﹤0.01% | 8141 |
|
|
2025
Q1 | $486K | Buy |
13,900
+200
| +1% | +$8.16K | ﹤0.01% | 8536 |
|
|
2024
Q4 | $610K | Sell |
13,700
-25,100
| -65% | -$1.03M | ﹤0.01% | 8116 |
|
|
2024
Q3 | $1.77M | Sell |
38,800
-39,100
| -50% | -$1.58M | ﹤0.01% | 5771 |
|
|
2024
Q2 | $2.59M | Sell |
77,900
-21,200
| -21% | -$867K | ﹤0.01% | 4837 |
|
|
2024
Q1 | $4.75M | Sell |
99,100
-21,000
| -17% | -$1.22M | ﹤0.01% | 4028 |
|
|
2023
Q4 | $8.85M | Buy |
120,100
+12,200
| +11% | +$825K | ﹤0.01% | 3008 |
|
|
2023
Q3 | $7.88M | Sell |
107,900
-900
| -0.8% | -$71.9K | ﹤0.01% | 2986 |
|
|
2023
Q2 | $9.02M | Sell |
108,800
-18,100
| -14% | -$1.58M | ﹤0.01% | 2816 |
|
|
2023
Q1 | $11.3M | Buy |
126,900
+10,500
| +9% | +$914K | ﹤0.01% | 2644 |
|
|
2022
Q4 | $9.97M | Sell |
116,400
-21,100
| -15% | -$1.79M | ﹤0.01% | 2851 |
|
|
2022
Q3 | $9.83M | Buy |
137,500
+37,720
| +38% | +$3.37M | ﹤0.01% | 2795 |
|
|
2022
Q2 | $9.7M | Sell |
99,780
-40,520
| -29% | -$4.13M | ﹤0.01% | 2728 |
|
|
2022
Q1 | $15.8M | Sell |
140,300
-100,100
| -42% | -$10.7M | ﹤0.01% | 2288 |
|
|
2021
Q4 | $32.5M | Buy |
240,400
+27,200
| +13% | +$3.79M | 0.01% | 1533 |
|
|
2021
Q3 | $30.1M | Sell |
213,200
-44,100
| -17% | -$5.93M | 0.01% | 1562 |
|
|
2021
Q2 | $33M | Buy |
257,300
+100,000
| +64% | +$11.8M | 0.01% | 1514 |
|
|
2021
Q1 | $20.1M | Buy |
157,300
+84,400
| +116% | +$15.6M | ﹤0.01% | 1956 |
|
|
2020
Q4 | $13.1M | Sell |
72,900
-44,900
| -38% | -$9.98M | ﹤0.01% | 2298 |
|
|
2020
Q3 | $25.8M | Buy |
117,800
+58,700
| +99% | +$13.1M | 0.01% | 1351 |
|
|
2020
Q2 | $13.2M | Buy |
59,100
+36,300
| +159% | +$5.69M | ﹤0.01% | 1914 |
|
|
2020
Q1 | $2.23M | Buy |
22,800
+16,300
| +251% | +$1.32M | ﹤0.01% | 3965 |
|
|
2019
Q4 | $488K | Buy |
6,500
+2,900
| +81% | +$187K | ﹤0.01% | 6836 |
|
|
2019
Q3 | $221K | Sell |
3,600
-8,100
| -69% | -$487K | ﹤0.01% | 8025 |
|
|
2019
Q2 | $694K | Buy |
11,700
+7,200
| +160% | +$432K | ﹤0.01% | 6295 |
|
|
2019
Q1 | $295K | Sell |
4,500
-7,200
| -62% | -$436K | ﹤0.01% | 7640 |
|
|
2018
Q4 | $571K | Sell |
11,700
-600
| -5% | -$35.8K | ﹤0.01% | 6204 |
|
|
2018
Q3 | $802K | Buy |
12,300
+7,600
| +162% | +$531K | ﹤0.01% | 5927 |
|
|
2018
Q2 | $313K | Sell |
4,700
-1,600
| -25% | -$96.7K | ﹤0.01% | 7140 |
|
|
2018
Q1 | $326K | Buy |
+6,300
| New | +$293K | ﹤0.01% | 6612 |
|
|
2017
Q4 | – | Sell |
-7,200
| Closed | -$316K | – | 8343 |
|
|
2017
Q3 | $316K | Buy |
+7,200
| New | +$251K | ﹤0.01% | 5989 |
|
|
2016
Q1 | – | Sell |
-600
| Closed | -$13K | – | 7730 |
|
|
2015
Q4 | $13K | Sell |
600
-4,600
| -88% | -$93.4K | ﹤0.01% | 8174 |
|
|
2015
Q3 | $98K | Sell |
5,200
-700
| -12% | -$15K | ﹤0.01% | 6973 |
|
|
2015
Q2 | $135K | Buy |
5,900
+3,500
| +146% | +$81.5K | ﹤0.01% | 6763 |
|
|
2015
Q1 | $65K | Buy |
2,400
+600
| +33% | +$15.3K | ﹤0.01% | 7207 |
|
|
2014
Q4 | $52K | Buy |
+1,800
| New | +$48.8K | ﹤0.01% | 7163 |
|
|
2014
Q3 | – | Sell |
-200
| Closed | -$4K | – | 8341 |
|
|
2014
Q2 | $4K | Sell |
200
-200
| -50% | -$4.6K | ﹤0.01% | 7763 |
|
|
2014
Q1 | $11K | Buy |
+400
| New | +$11.7K | ﹤0.01% | 7489 |
|
Other funds holding QDEL
NM
VPM
RCMNY
VCM
Citadel Advisors's QDEL Position: Q4 2025 in Review
Citadel Advisors sold out of QuidelOrtho (QDEL) in Q4 2025, closing a stake of 169,010 shares — an estimated $4.58M sold.
Citadel Advisors first reported a position in QDEL in Q1 2014 and held it in 41 quarters. The position peaked at $90.5M in Q3 2022. 244 funds tracked by Wall St. Rank hold QDEL as of Q4 2025.
- Citadel Advisors reported no remaining QuidelOrtho position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 169,010 QuidelOrtho shares in Q4 2025, an estimated $4.58M.
- Citadel Advisors first reported a position in QuidelOrtho in Q1 2014 and held it in 41 quarters.
- Citadel Advisors's QuidelOrtho position peaked at $90.5M in Q3 2022.
- 244 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.